Electromed (ELMD) Cash & Equivalents (2010 - 2026)

Electromed (ELMD) has 17 years of Cash & Equivalents data on file, last reported at $17.0 million in Q1 2026.

• On a quarterly basis, Cash & Equivalents rose 11.47% year-over-year to $17.0 million in Q1 2026; TTM through Mar 2026 was $17.0 million, a 11.47% increase from a year earlier, with the FY2025 full-year figure at $15.3 million, down 4.93% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $17.0 million, up from $13.8 million in the prior quarter.
• Over the last five years, Cash & Equivalents for ELMD reached as high as $17.0 million in Q1 2026 and fell as low as $6.0 million in Q3 2022.
• Historically, Cash & Equivalents has averaged $11.5 million across 5 years, with a median of $11.7 million in 2024.
• Across the five-year window, Cash & Equivalents plunged 45.37% in 2022 and surged 118.12% in 2024, its largest moves.
• Year by year, Cash & Equivalents stood at $6.9 million in 2022, then jumped by 51.02% to $10.4 million in 2023, then surged by 55.6% to $16.2 million in 2024, then slipped by 15.05% to $13.8 million in 2025, then gained by 23.16% to $17.0 million in 2026.
• Per Business Quant data, the three most recent Cash & Equivalents figures were $17.0 million in Q1 2026, $13.8 million in Q4 2025, and $14.1 million in Q3 2025.